VANESSA BOSTWICK
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner WINSTON SALEM, NC NPI 1609346147
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner NC Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$2,748.19
- Category: General Payments
- Program years: PY2021–2024
- Record count: 31
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $586.31 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $496.36 | 6 |
| Education | $89.95 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $125.00 | 1 |
| GENZYME CORPORATION | $120.27 | 1 |
| Genmab U.S., Inc. | $112.32 | 1 |
| E.R. Squibb & Sons, L.L.C. | $94.67 | 1 |
| SANOFI-AVENTIS U.S. LLC | $89.95 | 1 |
| Acerta Pharma LLC | $27.38 | 1 |
| Janssen Scientific Affairs, LLC | $16.72 | 1 |
By program year
Records — PY2024 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078854198 | Janssen Scientific Affairs, LLC | $16.72 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1101228967 | E.R. Squibb & Sons, L.L.C. | $94.67 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104282333 | AstraZeneca Pharmaceuticals LP | $27.38 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1126839590 | Genmab U.S., Inc. | $112.32 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1139785719 | SANOFI-AVENTIS U.S. LLC | $89.95 | 03/13/2024 | Education | Undisputed | 01/23/2026 | View at CMS |
| 1139785803 | GENZYME CORPORATION | $120.27 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1144972390 | Takeda Pharmaceuticals U.S.A., Inc. | $125.00 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.